34
- Comedics (Nasdaq:CRMD) announced Monday that it has signed a five-year commercial supply agreement with Florida-based dialysis provider ARC Dialysis for the supply of DefenCath (taurolidine and heparin).
- CRMD plans to begin commercializing DefenCath for inpatient use on April 15th.
- press release